pharmaphorum

NOVEMBER 20, 2022

Elizabeth Holmes, the founder and former chief executive of blood testing biotech Theranos, has been sentenced after being convicted of defrauding investors in the company earlier this year, receiving a prison sentence of more than 11 years in a California court. That’s shorter than the 15 years sought by prosecutors, but considerably longer than the 18 months’ house arrest that Holmes’ defense attorneys had pushed for, and there is likely to be an appeal against the sentence,

FDA 122

FDA 122

Drug Store News

NOVEMBER 20, 2022

CVS Health is investing $6.2 million to build 36 new affordable housing units in Bel Aire, Kan., and $14.3 million to build 120 affordable housing units in Seattle, Wash.

116

116

Pharmaceutical Technology

NOVEMBER 20, 2022

The UK's National Institute for Health and Care Excellence (NICE) has published a draft guidance that does not recommend the use of five major Covid-19 therapies. This news came as many organisations and patient advocacy groups have been campaigning for the adoption of some of the rejected drugs for several months, amidst concerns about access to medicines in the UK.

Hospitals 111

Hospitals 111

Fierce Healthcare

NOVEMBER 20, 2022

Walgreens plots 'aggressive' strategy to build out healthcare services, CEO Roz Brewer says. hlandi. Sun, 11/20/2022 - 18:20.

120

120

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

NOVEMBER 20, 2022

The COVID-19 pandemic stopped the world in its tracks. It provided a range of new challenges for industry stakeholders, including governments, public health bodies, and regulatory agencies – to name a few. In addition, it offered the opportunity for new solutions and approaches to many of today’s healthcare challenges. The world responded to the crisis at unprecedented speed, as leaders and experts focused on different ways to operate and succeed within the constraints of a new dynamic.

Vaccines 98

Vaccines Immunization 98

Drug Store News

NOVEMBER 20, 2022

These days, many U.S. consumers also want a little something extra in the name of health and wellness.

105

105

Drug Store News

NOVEMBER 20, 2022

Fruth Pharmacy named Richardson its new chief financial officer in September.

98

98

Pharmaceutical Technology

NOVEMBER 20, 2022

Health Canada has granted expanded authorisation for Novavax ’s Covid-19 vaccine (Recombinant protein, Adjuvanted) [Nuvaxovid; NVX-CoV2373] as a homologous booster for usage in adults aged 18 and above. The vaccine is indicated for active immunisation to prevent the disease. The latest development was based on findings from a Phase II clinical trial of the vaccine in South Africa as well as from the Phase III Prevent-19 trial in the US and Mexico.

Vaccines 59

Vaccines Adverse Reactions Immunization 59

pharmaphorum

NOVEMBER 20, 2022

Immatics has become the latest partner for GSK in the area of cell therapy for cancer to see its alliance shelved, just two and a half years after being set up. In its third-quarter results update , the Tuebingen, Germany-based biotech said it had been informed by GSK in early October that it would be terminating their partnership announced in February 2020, adding that the decision was made “unrelated to the programmes and the progress achieved in the collaboration to date.” The de

59

59

Hospital Pharmacy Europe

NOVEMBER 20, 2022

Dupixent (dupilumab) has been recommended for EU approval as the first available treatment for patients with prurigo nodularis. According to a press release by the manufacturer, Sanofi, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the approval of Dupixent (dupilumab) in the EU to treat adults with moderate-to-severe prurigo nodularis who are candidates for systemic therapy.

Hospitals 52

Hospitals 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Med Ed 101

NOVEMBER 20, 2022

We’ve been doing some work lately to develop a chart of commonly used drugs with pharmacogenomic considerations. In anticipation of that table, I thought I’d share my top 5 medications that have pharmacogenomic considerations. If you are taking a board exam (BCMTMS, NAPLEX, BCACP, BCPS, or BCGP) soon, I would definitely pay a little closer […].

52

52

Hospital Pharmacy Europe

NOVEMBER 20, 2022

Anticoagulation reversal agents used for intracranial haemorrhage have similar levels of efficacy and safety according to a systematic review. The use of different anticoagulant reversal agents after an intracranial haemorrhage, provides a similar level of efficacy and safety according to the findings of a meta-analysis by US researchers. The direct oral anticoagulants (DOACs) are increasingly preferred over warfarin in DOAC-eligible patients with atrial fibrillation and patients with venous thr

Hospitals 52

Hospitals 52

BioPharm

NOVEMBER 20, 2022

This Application Note presents streamlined workflows for preparation of InstantPC and 2-AB labeled N-glycans coupled with analysis using Agilent LC/FLD/MS.

Labelling 40

Labelling 40

PharmExec

NOVEMBER 20, 2022

Webinar Date/Time: Thu, Dec 8, 2022 2:00 PM EST.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

BioPharm

NOVEMBER 20, 2022

Webinar Date/Time: Wed, Dec 14, 2022 11:00 AM EST.

40

40

BioPharm

NOVEMBER 20, 2022

Webinar Date/Time: Tue, Dec 6, 2022 11:00 AM EST.

40

40